Vivani Medical, Inc. (VANI) Reports Q3 Net Loss of $7.3M, Cash of $15.5M

Vivani reported a Q3 2026 net loss of $7.3M, compared with $6.5M in Q3 2025. Cash, cash equivalents and restricted cash totaled $15.5M at September 30, 2026, versus $20.8M at June 30, 2026.Material DetailsContext by AI AnalystThis is a clinical-stage company with limited disclosed operating metrics…